FMR LLC 13D and 13G filings for Vor Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-06 12:19 pm Sale | 2025-06-30 | 13G | Vor Biopharma Inc. VOR | FMR LLC | 104,634 1.700% | -216,491 (-67.42%) | Filing |
| 2025-05-12 10:20 am Purchase | 2025-03-31 | 13G | Vor Biopharma Inc. VOR | FMR LLC | 321,125 5.100% | 143 (+0.04%) | Filing |
| 2025-02-12 09:34 am Sale | 2024-12-31 | 13G | Vor Biopharma Inc. VOR | FMR LLC | 320,982 9.300% | -59,966 (-15.74%) | Filing |
| 2024-02-09 10:05 am Sale | 2024-02-08 | 13G | Vor Biopharma Inc. VOR | FMR LLC | 380,947 11.236% | -17,578 (-4.41%) | Filing |
| 2023-01-10 12:48 pm Purchase | 2023-01-09 | 13G | Vor Biopharma Inc. VOR | FMR LLC | 398,526 12.141% | 239,452 (+150.53%) | Filing |
| 2022-02-09 10:01 am Sale | 2022-02-08 | 13G | Vor Biopharma Inc. VOR | FMR LLC | 159,073 8.531% | -37,689 (-19.15%) | Filing |